Updating the MASH pharmacotherapy landscape: a network meta-analysis incorporating SGLT2 inhibitors and emerging combination therapies - Top-Institutions - MDSpire

Updating the MASH pharmacotherapy landscape: a network meta-analysis incorporating SGLT2 inhibitors and emerging combination therapies

By
Mengshi Tang
Yingxu Ma
Yating Wang
June 4, 2026
0 min

Frontiers In Endocrinology

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

#1

Mayo Clinic

Rochester, Minnesota
Key Differentiators
- Gastroenterology
- Pharmacology
#2

University of California San Diego

La Jolla, California
Key Differentiators
- Gastroenterology
- Pharmacology
#3

University of California, San Francisco

San Francisco, California
Key Differentiators
- Gastroenterology
- Pharmacology
#4

Virginia Commonwealth University School of Medicine

Richmond, Virginia
Key Differentiators
- Gastroenterology
- Pharmacology
#5

Indiana University School of Medicine

Indianapolis, Indiana
Key Differentiators
- Gastroenterology
- Pharmacology

Original Source(s)

Frontiers In Endocrinology

Updating the MASH pharmacotherapy landscape: a network meta-analysis incorporating SGLT2 inhibitors and emerging combination therapies

by Mengshi Tang, Yingxu Ma, Yating Wang
June 4, 2026

Related Content

Frontiers In Endocrinology

Metabolomic signatures mediate the association between physical frailty and metabolic dysfunction-associated steatotic liver disease: a prospective cohort study

Frontiers In Immunology

Immunological research landscapes and emerging immune mechanisms in HIV/HBV co-infection: a bibliometric analysis (2014–2024)

Bmc Gastroenterology

Electronic nose versus gas chromatography – mass spectrometry for diagnostic discrimination of advanced hepatocellular carcinoma by volatolomic analysis